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The results of postoperative irradiation 
for locally advanced carcinoma of the larynx
Andrzej Wieczorek, Jacek Fijuth1, Wojciech Michalski2
I n t r o d u c t i o n.  The aim of the study was to conduct a retrospective analysis of advanced laryngeal cancer patients treated
with postoperative radiotherapy in order to assess the clinical outcome and identify prognostic factors which may alter their
prognosis.  
M a t e r i a l  a n d  m e t h o d s.  We retrospectively reviewed the medical records of 165 patients with advanced laryngeal
carcinoma treated with postoperative radiotherapy between 1984 and 1996. Initially all patients underwent total laryngectomy
combined, in 91 cases, with unilateral or bilateral neck dissection. Postoperative irradiation was initiated within 15 to 162 days
after surgery (mean – 53 days). The total dose varied between 50-70 Gy with the fraction size of 2.0 Gy. The analysis of overall
survival and local control was performed using the actuarial method according to Kaplan and Meier. Sex, age, performance
status, T, N stages, primary tumor site, hemoglobin level, histological grade, involvement of lymph nodes, extracapsular
lymph node extension, surgical margin status, presence of extension of the primary beyond larynx and/or thyroid cartilage
invasion and/or subglottic extension and time from operation to start of radiotherapy were studied in multivariate analysis for
the prognostic significance for both overall survival and local control.
Re s u l t s.  The actuarial survival for the entire group of postoperatively irradiated patients was 0.70, 0.56 and 0.43 at two, five
and ten years respectively. The actuarial local control for the entire group of patients was 0.86, 0.78 and 0.75 at one, two and
three years respectively and remained stable thereafter. For the overall survival – sex, positive lymph nodes and time interval
between surgery and radiotherapy were found to be the significant prognostic factors. For the local control the extracapsular
lymph node extension was found to be the only significant prognostic factor.
C o n c l u s i o n s.  Combined surgery and postoperative radiotherapy is an effective treatment modality in the management of
locally advanced laryngeal cancer. In multivariate analysis pathologically positive lymph nodes and the time interval between
surgery and radiation were found to be the significant prognostic factors influencing the overall survival. The extra-capsular
lymph node extension was found to be the only significant prognostic factor affecting local control. 
In order to decrease the local recurrence rate we postulate the use of the boost dose up to 70 Gy to the small volume in the cases
where capsular rupture was noticed. We recommend to start postoperative radiotherapy as soon as healing is adequate.
Shortening the interval between surgery and radiation is not associated with a significant increase in treatment toxicity.
Ocena wyników pooperacyjnego napromieniania chorych 
na miejscowo zaawansowanego raka krtani
W s t ´ p.  Celem pracy by∏a retrospektywna analiza wyników pooperacyjnej radioterapii u chorych na zaawansowanego raka
krtani oraz ocena wp∏ywu czynników prognostycznych klinicznych i terapeutycznych na rokowanie.
M a t e r i a ∏.  Materia∏ kliniczny stanowi∏a grupa 165 chorych na miejscowo zaawansowanego raka krtani, leczonych w latach
1985-1996, u których przeprowadzono uzupe∏niajàce pooperacyjne napromienianie. Wszyscy chorzy mieli wczeÊniej wykonany
zabieg operacyjny, polegajàcy na ca∏kowitym usuni´ciu krtani, po∏àczonym w 91 przypadkach z jednostronnà lub obustronnà
operacjà w´z∏ów ch∏onnych szyi. Czas od operacji do rozpocz´cia napromieniania po operacji wyniós∏ od 15 do 162 dni
(Êrednia 53). Dawka ca∏kowita waha∏a si´ od 50 Gy do 70 Gy przy dawce frakcyjnej 2 Gy. Analizie poddano czas prze˝ycia
oraz czas do miejscowego nawrotu. Prawdopodobieƒstwo prze˝ycia obliczano metodà Kaplana-Meiera. Zbadano wp∏yw: p∏ci,
wieku, stopnia sprawnoÊci, stopni zaawansowania T i N, lokalizacji nowotworu, poziomu hemoglobiny, stopnia zró˝nicowania
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Introduction
Advanced laryngeal squamous cell carcinoma (Stage III
and IV) is commonly managed by radical surgery and
postoperative radiotherapy. The use of adjuvant irradia-
tion was developed empirically as elective treatment of
subclinical disease present at tumour bed and regional
lymphatic areas after primary operation [1]. The concept
of combining both treatment modalities has been widely
applied since the early sixties [2-4]. The problem of the ef-
ficacy of such a treatment policy compared to surgery
alone has never been evaluated in prospective randomised
clinical trials. It was only assessed in retrospective analy-
ses [3-5]. The rationale for postoperative irradiation has
been to decrease the risk of tumour recurrence at the
primary site and in cervical and supraclavicular nodal re-
gions and therefore to improve the treatment outcome.
An advantage attributed to postoperative irradiation over
preoperative one is better outcome and ability to identify
the patients at risk for tumour recurrence following the
detailed study of surgical specimens [5].
Although postoperative radiotherapy is the main-
stay of treatment of advanced laryngeal cancer, yet many
clinical problems connected with this sequential thera-
peutic option remain unanswered. The purpose of our
study was to conduct a retrospective analysis of advanced
laryngeal cancer patients treated with postoperative radio-
therapy in order to assess their clinical outcome and iden-
tify prognostic factors which may alter the prognosis.
Material and methods
We retrospectively reviewed the medical records of 165 patients
with advanced laryngeal carcinoma treated with postoperative
radiotherapy between 1984 and 1996 at The IInd Department of
Radiotherapy of The Maria Sklodowska-Curie Memorial Cancer
Center in Warsaw. The patient population consisted of 150 men
and 15 women. Mean age was 55.6 years (range 29-80 SD ±
9.8). The staging was performed according to the TNM UICC-
-classification of 1987 [6] and was based on preoperative clinical
examination. There were 5 (3%) stage T2 patients, 67 (42%)
T3 and 88 (55%) T4 cases. In 5 patients the T stage was not as-
sessed. The clinical nodal stage was described as N0 in 90 (56%)
patients, N1 in 33 (21%), N2 in 31(19%) and N3 in 7 (4%) cases.
In 4 patients the N stage was not assessed. In 90 cases the tumo-
ur was located in supraglottic larynx, in 46 cases it was described
as transglottic, in 28 cases glottic carcinoma was discerned, in the
remaining 1 patient the tumour was described as subglottic car-
cinoma. Initially all patients underwent total laryngectomy com-
bined, in 91 cases, with unilateral or bilateral neck dissection.
The surgical procedures were performed at the laryngology de-
partments of the Mazovian region, mainly (147 patients) in
Warsaw laryngology departments. The unilateral neck dissec-
tion was carried out in 73 patients (radical 54, modified 28 and
adenectomy in 9 cases) and bilateral in 18 patients (radical-1,
modified-5, radical and modified or adenectomy-12 cases).
In all cases but one (low differentiated solid carcinoma) pa-
thology reports revealed squamous cell carcinoma G1 in 15
(9%) patients, G2 in 69 (42%) and G3 in 17 (10%) cases. In
63 (38%) patients the histologic grade was not assessed.
Surgical margins were free of the tumor in 131 patients.
Residual mass was found in 2 patients. Nineteen patients had mi-
croscopic involvement and 12 had close surgical margins. Pa-
thologically positive lymph nodes were found in 61 patients; in 31
cases accompanied by extracapsular extension. Extension of the
the primary beyond larynx, thyroid cartilage invasion, subglottic
extension or their combination were found in 134 patients. All
patients with poor prognostic features present in pathological
findings were referred to the IInd Department of Radiotherapy
of our institution. The indications for postoperative radiothera-
py were: close or positive margins, extension of the primary bey-
ond larynx, thyroid cartilage invasion, subglottic extension, tumor
grade G3, positive nodes with or without extracapsular extension.
The haemoglobin level assessed before radiotherapy varied
between 9.5 g/dl and 15.4 g/dl (mean: 13.1 g/dl SD ±1.5).
Postoperative irradiation was initiated within 15 to 162
days after surgery (mean: 53 ± 27). The patients were treated
with 60-Co unit using the shrinking field technique. The daily do-
se was 2.0 Gy in all cases. The wedged parallel opposed lateral
head and neck fields were used with doses prescribed to the
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histologicznego, zaj´cia usuni´tych w´z∏ów ch∏onnych, przejÊcia nacieku poza torebk´ w´z∏a, stopnia doszcz´tnoÊci zabiegu
operacyjnego, obecnoÊci niekorzystnych cech rokowniczych, zwiàzanych z rozrostem guza pierwotnego (zejÊcie pod g∏oÊni´,
przejÊcie nacieku poza granice anatomiczne krtani, naciekanie chrzàstek lub kombinacja powy˝szych cech) oraz czasu
od operacji do rozpocz´cia radioterapii na czas prze˝ycia oraz czas do wystàpienia miejscowego nawrotu, pos∏ugujàc si´
modelem proporcjonalnego ryzyka D.R. Cox'a.
W y n i k i.  Prawdopodobieƒstwo prze˝ycia 2, 5 i 10 lat wynios∏o odpowiednio: 0,70, 0,56, 0,43. Prawdopodobieƒstwo 1,2 i 3-
letniego czasu prze˝ycia bez miejscowej wznowy wynios∏o odpowiednio: 0,86, 0,78 i 0.75 i po trzech latach pozosta∏o na
niezmienionym poziomie. Stwierdzono statystycznie istotny wp∏yw na prze˝ycie trzech czynników: p∏ci, zaj´cia w´z∏ów
ch∏onnych oraz czasu od operacji do rozpocz´cia radioterapii oraz jednego czynnika: obecnoÊci przejÊcia nacieku poza
torebk´ w´z∏a ch∏onnego, potwierdzonego w badaniu histopatologicznym na miejscowà wyleczalnoÊç. 
W n i o s k i.  Uzyskane wyniki wskazujà, ˝e pooperacyjna radioterapia jest skutecznà metodà leczenia chorych na
zaawansowanego raka krtani. W analizie wielowymiarowej znamiennymi statystycznie czynnikami rokowniczymi w  odniesieniu
do prze˝yç ogólnych sà: potwierdzone w badaniu histopatologicznym zaj´cie w´z∏ów ch∏onnych przez przerzuty raka i d∏ugoÊç
czasu mi´dzy zabiegiem operacyjnym i radioterapià oraz w odniesieniu do wyleczalnoÊci miejscowej przejÊcie nacieku poza
torebk´ w´z∏a ch∏onnego. W celu poprawienia miejscowej wyleczalnoÊci proponujemy podwy˝szenie dawki na ma∏à obj´toÊç
do 70 Gy u chorych z obecnoÊcià przejÊcia nacieku poza torebk´ w´z∏a. Uzupe∏niajàca radioterapia powinna byç rozpocz´ta
mo˝liwie szybko po wygojeniu si´ rany pooperacyjnej. Skrócenie czasu pomi´dzy zabiegiem operacyjnym i radioterapià nie
wp∏ywa w znaczàcy sposób na nasilenie odczynów popromiennych.
Key words: cancer larynx, postoperative radiotherapy, retrospective analysis
S∏owa kluczowe: rak krtani, pooperacyjna radioterapia, analiza retrospektywna
midplane in 160 patients. At 44-46 Gy the field size was reduced
to eliminate the spinal cord from the treatment volume. The
total dose of 60 Gy was given to 118 patients. The doses of 64 to
70 Gy were given to 27 patients with positive or close surgical
margins after another field reduction at 60.0 Gy. The total dose
below 60 Gy was given to 15 patients (range from 50-58). In
120 patients, the posterior neck was supplemented with the elec-
trons uni or bilateral to doses ranged from 50 to 60 Gy. The
stoma was boosted additionally with electrons in 8 patients with
subglottic extension up to 10-16 Gy. The lower neck was irradia-
ted through an anterior supraclavicular portal with the dose
prescription to the maximum in 145 cases. The average total
dose was 50 Gy in 20 fractions (132 patients). Only in 13 patients
the dose of 45 Gy in 18 fractions was given. In the early eighties
(5 patients) an old technique with the one anterior field with do-
ses 50-56 Gy in 25-28 fractions had been used. The total treat-
ment time varied between 30 and 107 days (mean: 50 SD ±
11). Acute and late radiation morbidity were scored according to
the EORTC/RTOG scale [7].
The follow-up ranged from 5 to 163 months. In 50% of li-
ving patients the observation period was longer than 60 months
and in 75% – longer than 39 months. Only two patients were lost
from the follow-up after a time shorter than two years (5 and 21
months). The follow-up studies included clinical evaluations,
chest x-rays and other diagnostic procedures wherever appro-
priate.The overall survival and local control was calculated
using the actuarial method according to Kaplan and Meier. The
prognostic factor analysis was performed by means of the
Cox's proportional hazards model using a backward selection
method.
Results
The actuarial survival with standard deviation for the
entire group of postoperatively irradiated patients was
0.70 ±0,04, 0.56 ±0,04 and 0.43 ±0,05 at two, five and ten
years respectively (Figure 1). Local recurrence was defi-
ned as any recurrence above the clavicles, and 41 such
events were observed. In 15 cases distant metastases oc-
curred. Both types of relapses were lethal in all cases.
The total number of deaths in the observed group was 78.
Apart from the treatment failure listed above, other cau-
ses of death were: a second malignancy (mainly lung can-
cer) in 15 cases, cardiac disease in 5 cases. Death from
unknown causes occurred in 2 patients.
The actuarial local control with standard deviation
for the entire group of the patients was 0.86 ±0,03, 0.78
±0,04 and 0.75 ±0,03 at one, two and three years respec-
tively and remained stable thereafter (figure2).
Sex, age, performance status, T, N stages, primary
tumor site, hemoglobin level, histological grade, involve-
ment of lymph nodes, extracapsular lymph node exten-
sion, surgical margin status, presence of extension of the
primary beyond larynx and/or thyroid cartilage invasion
and/or subglottic extension and the time from operation
to start of the radiotherapy were studied in the multifac-
tors analysis for prognostic significance for both overall
survival and local control.
For overall survival – sex, positive lymph nodes
and the time interval between surgery and radiothe-
rapy were found to be the significant prognostic fac-
tors. The relative risk of death for men was 4 fold hi-
gher than the appropriate risk for women (p=0.05). The
relative risk of death in patients with positive lymph no-
des was almost 3.5 fold higher than in those with the ne-
gative lymph nodes (p=0.006). According to the length
of time from operation to radiotherapy patients were
divided uniformly into 5 groups: <32, [32, 44), [44, 52),
[52, 73) and ≥73 days. Longer periods between opera-
tion and radiation were associated with poorer prognosis.
The relative risk of death for patients waiting about two
months to start postoperative radiotherapy was 3 fold
bigger than those waiting less than one month (p=0.007).
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Figure 1. Overall survival probability
For patients waiting longer than 73 days a decrease in
the relative risk of death to 1.29 was observed. The results
of the regression analysis for death risk function were
presented in Table I. The survival probability for signifi-
cant prognostic factors is presented in Table II and Figu-
res 3 and 4.
Extracapsular lymph node extension was found to
be the only significant prognostic factor for local control.
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Table I. Multivariate analysis of factors influencing overall survival
Variable (reference level) B - coefficient Standard deviation Critical level of test (p) Relative risk (RR)
Sex (male) -1. 42 0. 73 0. 050 0. 24
Nodal Status
(without lymphadenectomy) 0. 002
pN- -0. 56 0. 44 0. 208 0. 57
pN+ 0. 67 0. 24 0. 006 1. 95
Time from operation to
radiotherapy (days)
(>32) 0. 043
[32, 44) 0. 56 0. 41 0. 175 1. 74
[44, 52) 0. 83 0. 40 0. 035 2. 30
[52, 73) 1. 04 0. 38 0. 007 2. 83
≥73 0. 26 0. 44 0. 556 1. 29
Table II. Survival probability for statistically significant variables
Survival 2 - years 5 - years 10 - years
Sex
males 0. 70 ± 0. 04 0. 53 ± 0. 04 0. 43 ± 0. 05
females 0. 93 ± 0. 07 0. 93 ± 0. 07 0. 47 ± 0. 33
pN
pN- 0. 86 ± 0. 08 0. 75± 0. 10 0. 66 ± 0. 11
pN+ 0. 62 ± 0. 07 0. 35 ± 0. 07 0. 26 ± 0. 07
Time from operation to radiotherapy (days)
<32 0. 74 ± 0. 08 0. 63 ± 0. 09 0. 63 ± 0. 09
[32, 44) 0. 69 ± 0. 08 0. 61 ± 0. 09 0. 46 ± 0. 12
[44, 52) 0. 65 ± 0. 08 0. 44 ± 0. 09 0. 39 ± 0. 10
[52, 73) 0. 61 ± 0. 08 0. 43 ± 0. 09 0. 23 ± 0. 10
≥73 0. 83 ± 0. 07 0. 70 ± 0. 09 0. 50 ± 0. 14
Figure 2. Local control probability
The patients with the presence of this pathologic feature
had a 3.5 fold higher relative risk of failure above the
clavicles than the group in which the extracapsular lymph
node extension was not observed (p=0.007). The results
of regression analysis for risk of local failure function are
presented in Table III. The probability of freedom from
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Figure 3. Overall survival probability according to pathologic nodal status
Figure 4. Overall survival probability according to interval between radiotherapy and surgery
Table III. Multivariate analysis of factors influencing local control
Variable (reference level) B - coefficient Standard deviation Critical level of test (p) Relative risk (RR)
Extracapsular lymph node extension 1. 30 0. 49 0. 007 3. 68
locoregional recurrence according to the extracapsular
lymph node extension is shown in Figure 5.
In most cases acute and late toxicity was low or mo-
derate (G0, G1, G2). Severe acute side effects were obse-
rved in a minority of the patients and were manageable.
The most affected organ was the skin, with 65 (40%) cases
of G3 and 5 (3%) with G4 grade toxicity. Severe acute
morbidity from the mucous membrane and the pharynx
and oesophagus was less frequent. There were 19 (12%)
cases of G3, 2 (1%) cases of G4 and 15 (9%) cases of
G3 toxicity respectively. Severe late skin radiation morbi-
dity (G3 and G4) was observed in 11 (7%) patients. All
these patients were managed with conservative treatment.
One patient needed surgical intervention because of oeso-
phageal stricture and it was the only case of severe late to-
xicity observed in other than cutaneous tissues. In order to
assess the intensification of both acute and late toxicity we
compared in an additionally performed statistical analysis
of the group of patients who started radiotherapy before
32 days from the operation to the rest of our patients.
We did not observe any statistically significant differences
between the studied groups. We only observed increased
early skin toxicity in the patients who started radiothera-
py earlier than 32 days from the surgery but this reached
only borderline statistical significance (p=0.051).
Discussion
The locally advanced laryngeal carcinoma remains a serio-
us clinical problem, however combined surgery and posto-
perative radiotherapy allow to achieve high rates of local
control and improved survival. In our study overall survi-
val was 56% and 43%, respectively, at 5 and 10 years. It
should be emphasized that patient population with the ad-
vanced laryngeal carcinoma includes a the large propor-
tion of heavy smokers who are at higher risk of having
heart and lung diseases and a propensity for developing
second malignances, mainly in the aerodigestive tracts.
In our study 28% causes of death were related to this
phenomenon. Second malignances and cardiovascular
diseases constituted all causes of death in the patients
with longer than five year periods of observation causing
over-mortality in the studied population. Treatment failu-
re (local and/or distant) remains the main cause of death
during first five years of observation in the study group
– 72% of all deceases. Local recurrence was the leading
reason of mortality (53% causes of death) and dominated
during the first two years of the observation. The
three-year local control in our group of patients was 75%
and remained stable thereafter.
The clinical results of the combined treatment in
our institution were similar to those achieved in other
institutions worldwide [8-11]. The distant metastases oc-
curred in 15 patients and constituted 9% of the entire
studied group and 19% of all causes of death. In the pu-
blished studies the percentage of the occurrence of di-
stant failure varied from 4.4% to 25% [8, 9, 12-16].
The extracapsular lymph node extension was found
to be the only significant prognostic factor affecting the
local control in the multivariate analysis performed on
our group of patient. The literature concerning prognostic
factors reported that the involvement of lymph nodes ac-
companied by the extracapsular extension [3, 9-13, 17-
20] and the positive surgical margin status [4, 8, 14, 20-26]
are the strongest pathologic features affecting negatively
disease control above the clavicles.
The finding of pathologically positive nodes without
capsular rupture is also recognized as a prognostically si-
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Figure 5. Local control probability according to extracapsular lymph node extension
gnificant factor for local control in the patients treated
with postoperative irradiation [8, 9, 11, 12, 15, 21, 26].
Only few reports found that low histological grade [14, 26,
27], presence of the extension of the primary beyond the
larynx [21], the thyroid cartilage invasion [21] and the
subglottic extension [28, 29] could be assumed as having
influence on locoregional recurrence.
In our treatment policy we did not use the boost do-
ses over 60 Gy for the nodal areas affected by the extra-
capsular extension. We now recognize the extracapsular
extension as the similar clinical situation to the non-radi-
cal surgical excision and therefore based on our present
experience we are going to introduce the use of the boost
dose up to 70 Gy to small volume where the capsular
rupture was noticed. Such a treatment policy requires ca-
reful description in the pathological report affected gro-
ups of the cervical lymph nodes according to the Rob-
bins Classification and the very precise 3-D treatment
planning [30].
In our study pathologically positive nodes were fo-
und to be a statistically significant factor in the multivaria-
te analysis having negative influence on the overall su-
rvival. In a series published elsewhere this factor [8, 9,
11, 12, 15, 21, 26] along with positive surgical margin sta-
tus [4, 8, 14, 20-25] and high histological grade [11, 16, 26]
were claimed as increasing risk of death in the head and
neck cancer patients managed with postoperative radio-
therapy.
Analyses of the dose-response relationship for ra-
diation therapy of subclinical disease have suggested, that
the interval between operation and radiotherapy could
influence the clinical outcome of the treatment [31, 32]. It
is commonly accepted that a delay in the initiation of the
postoperative irradiation beyond 6 weeks after surgery
worsens prognosis. Although such a belief is very strong
among clinicians there were, however, few available data
to support it [33-35].
In our study the interval between surgery and radia-
tion was a statistically significant factor influencing overall
survival. We did not observe this feature to be a variable
predicting the local control and we cannot find any reason
to explain this fact.
We did not notice increased radiation morbidity in
the patients who started treatment earlier than 32 days
from the operation compare to those starting later.
In the recently published retrospective analysis of
postoperatively irradiated patients with head and neck
cancer [36] and randomised trial addressing time factors
of surgery plus radiotherapy in advanced head and neck
cancer [37] a prolonged interval between operation and
radiotherapy was found to be associated with a signifi-
cantly lower local control [36, 37] and survival [37]. The
cumulative duration of combined therapy was also found
in both papers to significantly impact on the local control
[36, 37] and survival [37] rates. Based on our experience,
despite the interval between surgery and radiation in our
study proved to be affecting only overall survival, and on
cited above results of the recently published papers, we
recommend to start postoperative radiotherapy as soon
as healing is adequate. The shortening of the interval
between surgery and radiation is not associated with the
significant raise in the treatment toxicity.
The reasons for the radiotherapy delay in our study
were not assessed because of the insufficient data in the
analysed clinical material. In a recently published series
[36, 37] the reasons of delay of radiotherapy were speci-
fied, but they were not considered as variables for the
statistical analyses. We think that performing such an
analysis would be valuable and may elucidate the ways
of influencing clinical outcome by prolonging total treat-
ment time.
Radical surgery and postoperative radiotherapy sho-
uld be considered as one treatment that needs to be deli-
vered in a timely and coordinated fashion.
There is still room for improving the outcome of
this treatment by exploring the role of accelerated radio-
therapy [37] and combining chemotherapy with irradia-
tion [38].
Conclusions
Combined surgery and postoperative radiotherapy is an
effective treatment modality in the management of locally
advanced laryngeal cancer. In multivariate analysis patho-
logically positive lymph nodes and time interval between
surgery and radiation were found to be the significant
prognostic factors influencing the overall survival. The
extra- capsular lymph node extension was found to be the
only significant prognostic factor affecting local control.
In order to decrease the local recurrence rate we
postulate the use of the boost dose up to 70 Gy to the
small volume in the cases where capsular rupture was
noticed.
We recommend to start postoperative radiotherapy
as soon as healing is adequate. The shortening of interval
between surgery and radiation is not associated with the
significant raise in treatment toxicity.
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